Anti-NR5A2 monoclonal antibody

Pre-made anti-NR5A2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NR5A2/NR5A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T13902-Ab-1/ GM-Tg-hg-T13902-Ab-2Anti-Human NR5A2 monoclonal antibodyHuman
GM-Tg-rg-T13902-Ab-1/ GM-Tg-rg-T13902-Ab-2Anti-Rat NR5A2 monoclonal antibodyRat
GM-Tg-mg-T13902-Ab-1/ GM-Tg-mg-T13902-Ab-2Anti-Mouse NR5A2 monoclonal antibodyMouse
GM-Tg-cynog-T13902-Ab-1/ GM-Tg-cynog-T13902-Ab-2Anti-Cynomolgus/ Rhesus macaque NR5A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T13902-Ab-1/ GM-Tg-felg-T13902-Ab-2Anti-Feline NR5A2 monoclonal antibodyFeline
GM-Tg-cang-T13902-Ab-1/ GM-Tg-cang-T13902-Ab-2Anti-Canine NR5A2 monoclonal antibodyCanine
GM-Tg-bovg-T13902-Ab-1/ GM-Tg-bovg-T13902-Ab-2Anti-Bovine NR5A2 monoclonal antibodyBovine
GM-Tg-equg-T13902-Ab-1/ GM-Tg-equg-T13902-Ab-2Anti-Equine NR5A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T13902-Ab-1/ GM-Tg-hg-T13902-Ab-2; GM-Tg-rg-T13902-Ab-1/ GM-Tg-rg-T13902-Ab-2;
GM-Tg-mg-T13902-Ab-1/ GM-Tg-mg-T13902-Ab-2; GM-Tg-cynog-T13902-Ab-1/ GM-Tg-cynog-T13902-Ab-2;
GM-Tg-felg-T13902-Ab-1/ GM-Tg-felg-T13902-Ab-2; GM-Tg-cang-T13902-Ab-1/ GM-Tg-cang-T13902-Ab-2;
GM-Tg-bovg-T13902-Ab-1/ GM-Tg-bovg-T13902-Ab-2; GM-Tg-equg-T13902-Ab-1/ GM-Tg-equg-T13902-Ab-2
Products NameAnti-NR5A2 monoclonal antibody
Formatmab
Target NameNR5A2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NR5A2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T13902-Ag-1Recombinant multi-species NR5A2/ B1F/ B1F2 protein
    ORF Viral VectorpGMLPm004395mouse Nr5a2 Lentivirus plasmid
    ORF Viral VectorvGMLPm004395mouse Nr5a2 Lentivirus particle


    Target information

    Target IDGM-T13902
    Target NameNR5A2
    Gene ID2494,26424,60349,709735,490252,101094231,541305,100009700
    Gene Symbol and SynonymsB1F,B1F2,CPF,D1Ertd308e,FTF,FTZ-F1,FTZ-F1beta,hB1F-2,LRH-1,LRH1,NR5A2,SF-2,UF2-H3B
    Uniprot AccessionO00482,Q9QWM1
    Uniprot Entry NameNR5A2_HUMAN,NR5A2_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000116833
    Target ClassificationTumor-associated antigen (TAA)

    The target: NR5A2, gene name: NR5A2, also named as B1F, B1F2, CPF, FTF, FTZ-F1, FTZ-F1beta, LRH-1, LRH1, hB1F-2. The protein encoded by this gene is a DNA-binding zinc finger transcription factor and is a member of the fushi tarazu factor-1 subfamily of orphan nuclear receptors. The encoded protein is involved in the expression of genes for hepatitis B virus and cholesterol biosynthesis, and may be an important regulator of embryonic development. [provided by RefSeq, Jun 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.